- The trend backdrop is active with a 48-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
GRANULES
NSI
Week ended 07 Aug 2026
Weekly Investor Report
Granules India Limited · Healthcare · Drug Manufacturers - Specialty & Generic
Latest close
873.8 INR
6.0%
latest week
Weekly setup
Mixed setup
The weekly trend is active. Price is 25.3% above the Trend Line and sits at 92.7% of its 52-week range. The latest completed week returned 6.0%, after a -1.6% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 61/100. Near-term considerations: price is close to its 52-week high; volume confirmation is below normal.
Setup score
73
out of 100
Latest Close
873.8 INR
7 Aug 2026
1W Return
6.0%
latest completed week
4W Return
-1.6%
short-term follow-through
12W Return
18.7%
quarterly tape
Trend Breadth
92.3%
48 of 52 weeks active
Volume Ratio
0.9x
vs 13-week average
- 17 reversal markers appear in the recent smart-money tape.
- Price is close to its 52-week high; watch for continuation or exhaustion.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
6.0%
Latest completed week; four-week move -1.6%.
Indicator stack
96/68
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Positive 55.42%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
61/100
25 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 25.3% above the Trend Line and sits at 92.7% of its 52-week range. The latest completed week returned 6.0%, after a -1.6% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.9x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.9512-week average 0.98
12-week confirmation
Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.95Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers1717 reversal markers
No recent accumulation markers. 17 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -1.6% over four weeks, 18.7% over 12 weeks, and 98.8% over one year. The current trend has remained active for 48 consecutive weeks.
Performance by holding period
Active trend streak48 weeks
Active weeks in one year48
Trend breadth92.3%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure1.07Latest activity-pressure read.
Pressure change-12.8%Four-week change in activity pressure.
Leadership37.98Latest relative-leadership reading.
RS change-23.5%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive.
Factor week 09 Aug 2026
Financial statements through 31 Mar 2026
Field coverage 91%
Model confidence 85%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength78/100Blend of value, momentum, and quality. Underlying universe rank 23; rank 1 is best.
Value32/100Relative valuation strength. Underlying universe rank 69; rank 1 is best.
Quality86/100Profitability and accounting quality. Underlying universe rank 15; rank 1 is best.
Momentum97/100Medium-term price momentum. Underlying universe rank 4; rank 1 is best.
Growth74/100Revenue and earnings growth. Underlying universe rank 27; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Value-quality framework47/100Value and quality alignment from the Sharemaestro SVQF framework.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 36.4x Price divided by trailing earnings.
- Price / sales
- 4.1x Market value relative to trailing revenue.
- EV / EBITDA
- 18.6x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- 1.1% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 64.9% Gross profit retained from each unit of revenue.
- Operating margin
- 16.7% Operating profit retained from revenue.
- Free-cash-flow margin
- 4.4% Free cash flow generated from revenue.
- Return on invested capital
- 11.7% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 19.8% Latest one-year revenue growth.
- EPS growth
- 16.1% Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- -20.3% Latest one-year free-cash-flow growth.
- Piotroski F-score
- 6/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- 0.2% Cash dividends relative to market value.
- Buyback yield
- -3.1% Net share repurchases relative to market value.
- Shareholder yield
- -2.9% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 0.5x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment61/100
Weighted news tone is neutral across 25 relevant articles.
13 positive · 12 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-3.8%Distance below the 52-week high.
13-week volatility4.1%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher15 of 2611 weeks finished lower.
Best week+9.1%Week of 3 Jul.
Worst week-5.4%Week of 24 Jul.
Latest week+6.0%Week of 7 Aug.
Shape of recent returns
Strong gains8
Modest gains7
Flat weeks0
Modest losses10
Sharp losses1
Recent vol4.1%13-week weekly-return volatility.
Base vol3.6%52-week weekly-return volatility.
Up/down split30/22Count of positive and negative weeks in the 52-week window.
Average skew3.9% / -2.0%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorIN Healthcare
4-week rank65 / 100
Group average1.2%
Trend breadth83.0%
Trend83.0%active weekly trend signals
MD85.0%positive activity pressure
RS73.0%positive relative leadership
Four-week leaders
IndustryIN Drug Manufacturers - Specialty & Generic
4-week rank51 / 92
Group average1.0%
Trend breadth76.1%
Trend76.1%active weekly trend signals
MD80.4%positive activity pressure
RS65.2%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape76/100
Trend, activity pressure, participation, and risk combine to a 76/100 tape read.
Indicator analysis82/100Latest 12-week confirmation: trend 12/12, activity pressure 12/12, relative leadership 12/12.
Activity pressure 0.95; 17 reversal markers Next-Week ExpectancyPositive 55.42%Next-week expectancy is positive with a 55.42% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors73/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 87 SVQF47/100Value and quality alignment from the Sharemaestro SVQF framework.
Composite rank 836.0 of 1576 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment61/100Weighted news tone is neutral across 25 relevant articles.
GRANULES Outlook for the Week (August 03, 2026 – August 07, 2026) Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 873.8 INR | 6.0% | 697.4 INR | 529.1 INR | 1.07 | 37.98 | 3.9M | On |
| 31 Jul 2026 | 824.5 INR | -0.9% | 688.3 INR | 525.4 INR | 1.34 | 32.92 | 3.9M | On |
| 24 Jul 2026 | 831.8 INR | -5.4% | 681.3 INR | 522.2 INR | 1.49 | 39.20 | 6.8M | On |
| 17 Jul 2026 | 879.0 INR | -1.0% | 674.2 INR | 518.9 INR | 1.37 | 45.46 | 5.2M | On |
| 10 Jul 2026 | 888.0 INR | 6.7% | 664.3 INR | 515.2 INR | 1.22 | 49.62 | 8.3M | On |
| 3 Jul 2026 | 832.1 INR | 9.1% | 653.9 INR | 511.5 INR | 0.97 | 41.84 | 1.3M | On |
| 26 Jun 2026 | 762.6 INR | -3.1% | 644.8 INR | 508.1 INR | 0.97 | 32.74 | 0 | On |
| 19 Jun 2026 | 786.9 INR | 2.7% | 638.0 INR | 505.1 INR | 1.27 | 38.60 | 1.8M | On |
| 12 Jun 2026 | 766.5 INR | -3.0% | 629.9 INR | 501.9 INR | 1.32 | 38.74 | 350.1K | On |
| 5 Jun 2026 | 789.8 INR | 2.1% | 622.6 INR | 498.9 INR | 1.44 | 45.97 | 591.9K | On |
| 29 May 2026 | 773.8 INR | 2.9% | 614.8 INR | 495.5 INR | 1.65 | 43.42 | 14.3M | On |
| 22 May 2026 | 752.0 INR | 2.1% | 607.8 INR | 492.4 INR | 1.69 | 39.71 | 4.1M | On |
| 15 May 2026 | 736.2 INR | -2.2% | 601.6 INR | 489.3 INR | 1.85 | 38.50 | 4.3M | On |
| 8 May 2026 | 753.0 INR | 7.6% | 596.0 INR | 486.4 INR | 1.80 | 39.84 | 9.3M | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.